New Developments in the Molecular Treatment of Ichthyosis: Review of the Literature
July 2022
in “
Orphanet journal of rare diseases
”
ichthyosis protein replacement gene therapy biological therapeutics immune pathways IL-17 TNF-α secukinumab ixekizumab ustekinumab dupilumab inflammation pruritus scaling enzyme replacement therapy lipid replacement therapy small molecules KLK5 inhibitors preclinical studies gene editing CRISPR/Cas9 X-linked ichthyosis Harlequin ichthyosis randomized controlled trials genetic mutations treatment responses CRISPR
Studysummary This review discusses recent advancements in therapies for ichthyosis, highlighting promising prospects in protein replacement and gene therapy, but it reports no new clinical results.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on ojrd.biomedcentral.com →